- Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma
-
Hyung J, Hong JY, Kim S, Ryu JS, Huh J, Suh C
- KMID: 2466596
- Blood Res.
- 2019 Dec;54(4):285-288.
- doi: 10.5045/br.2019.54.4.285
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- GASTric Cancer HER2 Re-Assessment Study 2 (GASTHER2): HER2 Re-assessment for Initially HER2-Negative Advanced Gastric Cancer Patients after Progression on First-Line Treatment
-
Hyung J, Kim HD, Ryu MH, Park YS, Moon M, Kang YK
- KMID: 2550336
- Cancer Res Treat.
- 2024 Jan;56(1):199-207.
- doi: 10.4143/crt.2023.490
Purpose Heterogeneous human epidermal growth factor receptor 2 (HER2) overexpression in gastric cancer may lead to a misdiagnosis of HER2 status. Accurate assessment of HER2 status is essential for optimal... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
-
Hyung J, Kim B, Yoo C, Kim KP, Jeong JH, Chang HM, Ryoo BY
- KMID: 2454282
- Cancer Res Treat.
- 2019 Jul;51(3):901-909.
- doi: 10.4143/crt.2018.326
PURPOSE: Gemcitabine plus cisplatin (GemCis) is the standard first-line chemotherapy for patients with advanced biliary tract cancer (BTC). In ABC-02 study, the BTC patients received up to 6-8 cycles of... -
- CITED
-
- Close
- SHARE
-
- Close
- Correlations between the Left Ventricular Diastolic Function and Aortic Stiffness in Healthy Aged Subjects
-
Park HY, Lee SY, Cho SW, Kwon SU, Namgung J, Hyung J, Lee WR
- KMID: 2227125
- Korean Circ J.
- 2006 May;36(5):393-399.
- doi: 10.4070/kcj.2006.36.5.393
BACKGROUND AND OBJECTIVES: Arterial stiffness and wave reflections increase with advancing age, and the systolic and pulse pressures are elevated. These changes in aortic stiffness and pulse wave velocity with... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Small Cell Carcinoma of the Genitourinary Tract and the Prognostic Significance of the Tumor Immune Microenvironment
-
Hyung J, Kim HD, Kim GH, Cho YM, Ryu YM, Kim SY, Park I, Yoon S, Lee JL
- KMID: 2554351
- Cancer Res Treat.
- 2024 Apr;56(2):624-633.
- doi: 10.4143/crt.2023.1076
Purpose Small cell carcinoma of the genitourinary tract (GU SCC) is a rare disease with a poor prognosis. There are only limited treatment options due to insufficient understanding of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection
-
Lim DH, Yoon H, Kim Kp, Ryoo BY, Lee SS, Park DH, Song TJ, Hwang DW, Lee JH, Song KB, Kim SC, Hong SM, Hyung J, Yoo C
- KMID: 2547805
- Cancer Res Treat.
- 2023 Oct;55(4):1313-1320.
- doi: 10.4143/crt.2023.452
Purpose There are no reliable biomarkers to guide treatment for patients with borderline resectable pancreatic cancer (BRPC) in the neoadjuvant setting. We used plasma circulating tumor DNA (ctDNA) sequencing to... -
- CITED
-
- Close
- SHARE
-
- Close
- Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability‒High Colon Cancer
-
Hyung J, Cho EJ, Kim J, Kim JH, Kim JE, Hong YS, Kim TW, Sung CO, Kim SY
- KMID: 2534197
- Cancer Res Treat.
- 2022 Oct;54(4):1175-1190.
- doi: 10.4143/crt.2021.1133
Purpose Recent clinical trials have reported response rates < 50% among patients treated with programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors for microsatellite instability‒high (MSI-H) colorectal cancer (CRC), and factors... -
- CITED
-
- Close
- SHARE
-
- Close
